AcnePodcast Highlights

Systemic Antibiotics in the Management of Acne: Issues and Considerations for Optimal Care

By August 7, 2020September 7th, 2020No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

"Systemic Antibiotics in the Management of Acne: Issues and Considerations for Optimal Care"

Drs. Joslyn Kirby and Adam Friedman

 

WEEEEEEERE BACK! Join host Dr. Adam Friedman for lively and learned discussion with Dr. Joslyn Kirby on one of the most common, chronic, soul-crushing complaints… Acne Vulgaris. It is, from a pathophysiological standpoint, a biological sh*t show, but you need to understand it to develop the best treatment plans. We talk inflammation, first line approaches, setting patient expectations and compliance. We dive deep into the differences between broad-spectrum and narrow-spectrum antibiotics, when to use them, and for how long. (Spoiler alert: NOT TOO LONG!). In our efforts to be stewards of meaningful antibiotic use and adversaries of antimicrobial resistance, narrow-spectrum antibiotics are the future!

This enduring activity is supported by an independent medical education grant provided by Almirall, LLC.

Upon completion of this enduring, internet-based educational activity, participants should be able to:

  • Review current scientific understanding of pathophysiology of acne
  • Summarize acne treatment strategies utilizing systemic antibiotics
  • Differentiate safety and efficacy of broad and narrow spectrum antibiotics indicated for acne treatment
  • Cite the benefits of narrow spectrum antibiotic use in acne therapy
Listen Now
Disclosures:
  • Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speaker’s Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
  • Joslyn R. Sciacca Kirby, MD – No relevant disclosures.

You May Also Like

Filter Needed: Emerging Science in and Approaches to Sunscreen Safety

| Featured Articles, Featured Podcast, Latest News, Podcast Highlights, The Latest | No Comments
Sunscreen ... our daily epi/dermal defense, our solar safeguard, our broad-spectrum BFF for life. Yet lurking in the shaded areas are unfounded fears: “Sunscreen causes cancer; Sunscreen is an endocrine…

Ceut up: Incorporating a New OTC Concept into the Acne Armamentarium.

| Featured Articles, Featured Podcast, Latest News, Podcast Highlights, The Latest | No Comments
Acne Vulgaris... It pops up everywhere — in clinic, in conversation, and unfortunately, on our patients’ faces/trunks. While we’ve long leaned on prescription mainstays to zap zits, there’s a new family…

Podcasting on Podcasts: Dr. Adam Friedman and Dr. Jim Del Rosso Unpack the Mics

| Featured Articles, Latest News, Podcast Highlights, The Latest | No Comments
In this special edition of the JDD Podcast, host Dr. Adam Friedman flips the script on one of dermatology’s most recognizable voices, Dr. Jim Del Rosso, to explore the why,…

Leave a Reply